Male, 4-5-week-old, genetically diabetic mice (C57BL/KsJ dbldb) and non-diabetic heterozygote littermates (C57BL/KsJ db/ +).were fed on a diet containing 1 mg zinc/kg (low-Zn groups) or 54 mg Zn/kg (control groups) for 27 d. Food intakes and body-weight gain were recorded regularly. On day 28. after an overnight fast, animals were killed and blood glucose and insulin concentrations, liver glycogen, and femur and pancreatic Zn concentrations were determined.
The effect of zinc deficiency on insulin and carbohydrate metabolism has been studied in some detail in laboratory animals (Boquist & Lernmark, 1969; Huber & Gershoff, 1973; Brown et al. 1975; Reeves & O'Dell, 1983) but in many instances the findings are difficult to interpret because of the effect of dietary Zn depletion on food intake (Quaterman et al. 1966) . Consequently, there is no clear evidence demonstrating that inadequate dietary Zn is associated with changes in insulin secretion and action, although microscopic studies indicate that the p-cells of Zn-deficient animals have decreased granulations and histochemically detectable insulin (Boquist & Lernmark, 1969 ). An effect of low Zn status on hormonal action may, however, become apparent in conditions where insulin secretion and function are already abnormal. For example, it has been suggested that the altered Zn metabolism and reduced Zn status reported to occur in type I1 (maturity onset) diabetic subjects (Mooradian & Morley, 1987 ) may aggravate the insulin resistance which is characteristic of this condition (Kinlaw et al. 1983) . It has been speculated that where there is evidence of poor Zn status a programme of Zn repletion may improve insulin sensitivity and reduce the severity of some of the complications of this disease (Levine et al. 1983 ). There appears to be little information, however, on the effect of varying dietary Zn intake on the progression and severity of this form of diabetes.
In the present study a semi-synthetic diet containing either 1 or 54 mg Zn/kg was fed to 4-5-week-old male, genetically diabetic mice (C57BL/KsJ db + / d b + ). Diabetes (db) is inherited as a unit autosomal recessive and all mice homozygous for the diabetic gene (db/ mice were injected subcutaneously into the scruff with 37 kBq 65Zn (3.7-92.5 GBq/g Zn; Amersham International, Amersham, Bucks.) in 0. I ml saline (9 g sodium chloride/l). Immediately after injection, the mice were restrained within a well-ventilated perspex box (100 x 100 x 120 mm) and counted in a small-animal whole-body gamma counter (NE81 12; Nuclear Enterprises, Edinburgh) to determine the exact dose of isotope given to each animal. Counting geometry was such that the count from a radioactive 'point' source at any position in the box was within +0.5% of the overall mean. After the injection, half these animals continued to receive the control diet and half were given the low-Zn diet, and the amount of whole-body 65Zn lost over a 27 or 28 d period was measured by whole-body counting as described previously (Southon et al. 1988b ). On days 27 and 28 of the experiment the mice were killed between 10.00 and 13.00 hours by intraperitoneal injection of an overdose of sodium pentabarbitone (0.3 ml, 200 mg/ml ; Euthatal; May & Baker, Dagenham, Essex), one mouse from each group being killed at approximately the same time.
Before the administration of pentabarbitone a tail-blood sample was taken from each mouse and, after death, the pancreas and right femur were removed from a random selection of mice from each group, for Zn analysis. The number of observations made for each measurement in both experiments is given in the tables of results.
Analytical methods
Blood glucose was measured in 10 ,ul samples of fresh whole-blood by the glucose oxidase (EC 1.1.3.4) method, using a YSI Model 27 glucose analyser (Yellow Springs Inst. Inc., Ohio, USA).
Plasma insulin was determined by a radioimmunoassay as described previously (Southon et al. 1 9 8 8~) .
Glycogen was determined as glucose following enzymic hydrolysis with amyloglucosidase (EC 3.2.1.3) (Keppler & Dekker, 1974) .
The dried pancreas and femur were heated in silica crucibles at 480" for 48 h and the ash taken up in hot hydrochloric acid ( 1 1.7 M) for Zn analysis by atomic absorption (PU 9000 ; Pye Unicam, Cambridge).
Statistical analysis
Comparisons between the effect of diet and genotype were made using Student's unpaired t test.
RESULTS

Expt 1
Body-weight gain of the diabetic and heterozygote mice fed on a low-Zn diet for 28 d was not significantly different from their control counterparts (Table 1) . Although the growth rate of diabetic mice was similar in the two dietary groups, the total food intake of the lowZn diabetic animals was 7-8 % higher ( P < 001) than that of the control diabetic mice. The amount of food consumed by the low-Zn and control heterzygote mice was not significantly different. Values for body-weight gain and food intake were significantly higher for diabetic animals compared with the heterozygotes (Table 1) .
Femur and pancreatic Zn concentrations, taken as an index of Zn status, indicated that both the low-Zn diabetic and heterozygote mice were able to maintain a similar status to that of their control group (Table 1) . Total pancreatic Zn, however, was significantly lower in low-Zn diabetic mice compared with the controls. Pancreatic Zn concentration was significantly lower in all the diabetic animals compared with the heterozygotes. However, 
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because of the increased dry weight of pancreases from diabetic animals, differences in total Zn content were not so marked. In both experiments mean femur Zn concentrations for diabetic mice were lower than those for heterozygotes, but the difference was not always significant (Tables 1 and 3) . On day 27 of the study, time of feeding was controlled to allow a more accurate comparison of blood glucose and insulin concentrations between groups on day 28 when the mice were killed following an overnight fast. Food-intake measurements showed that Values within a horizontal line with different superscript letters were significantly different (P < 005).
* For details of animals and diets, see pp. 500-501. Values within a vertical column with different superscript letters were significantly different (P < 0.05).
* For details of animals and diets, see pp. 500-501.
there was no difference between genotypes or dietary groups in the amount of food consumed at either of the two meals on the day before sampling. Weights of food consumed at the last meal (mean with SEM) were (g) control groups: diabetic 0.9 (SEM 0.05), heterozygote 1.0 (SEM 0.1); low-Zn groups: diabetic 0.8 (SEM 0.07), heterozygote 0-8 (SEM 0.02). Analysis of fasting blood glucose and plasma insulin concentration and liver glycogen content, indicated that low-Zn diabetic mice had a similar plasma insulin concentration, a higher fasting blood glucose level (P < 005) and an increased liver glycogen content ( P < 0.05) compared with the control diabetic animals ( Table 2 ). The higher liver glycogen values in the low-Zn diabetic group were associated with a significant increase in liver weight (P < 0.05) together with a trend towards a higher glycogen concentration (P < 0-1) ( Table 2 ). Blood glucose and plasma insulin concentrations, and liver glycogen content were similar in both low-Zn and control groups of heterozygote mice (Table 2) . 
S U S A N SOUTHON A N D O T H E R S
Expt 2
The body-weight gain was similar in the low-Zn and control groups, with the diabetic mice having the greatest weight gain (Table 3) . Pancreatic and femur Zn concentrations in both diabetic and heterozygote mice were unaffected by the level of dietary Zn (Table 3) . In this second study, blood glucose concentration was measured following normal ad lib. feeding and, under these conditions, whole-blood glucose concentration was found to be significantly higher in each of the low-Zn groups killed after a 27 d feeding period ( P < 0.05), compared with mice fed on the control diet (Table 3) .
A whole-body 65Zn study, performed between approximately 4 and 8 weeks of age, showed that 65Zn loss was markedly lower at all time-points for animals fed on the lowZn diet (Table 4 , Fig. 1 ). Rate of 65Zn loss was similar in both the control groups, but lowZn diabetic mice had a significantly greater whole-body 65Zn loss (P < 0.05) over the 28 d period of study compared with heterozygotes fed on the same diet (Fig. 1) . Regression analysis of the log,, per cent rate of 65Zn loss, over the last 9 d indicated that the mean daily 65Zn loss was 2 and 1.3 % for low-Zn diabetic and heterozygote mice respectively.
DISCUSSION
Findings on growth rate, food intake and femur and pancreatic Zn concentrations indicated that the long-term consumption of a low-Zn semi-synthetic diet (1 mg Zn/kg) resulted in only a very mild deficiency state in the mice used in the present study, compared with the very severe deficiency which would have been observed in the laboratory rat fed on this level of Zn (Southon et al. 1984 ). It appears, therefore, that although the recommended dietary Zn concentration for mice is similar to that for rats (American Institute of Nutrition, 1977) , the minimum requirement of the mouse is very much lower.
In both experiments the body-weight gain of diabetic and heterozygote mice was not significantly affected by dietary Zn concentration (1 or 54 mg Zn/kg). The amount of food consumed by the heterozygote non-diabetic animals was also unaffected by dietary Zn concentration, but the diabetic mice fed on the low-Zn diet had a higher food intake than those fed on the control diet. This is surprising in view of the many studies demonstrating reduced appetite in animals fed on low-Zn diets (Mills er al. 1969) and raises the possibility that the degree and direction of response to dietary Zn depletion may be influenced by the metabolic state of the animal.
Pancreatic Zn concentrations were similar in dietary groups of the same genotype, despite the fact that this tissue is generally regarded to be one of the most sensitive to variation in dietary Zn intake (Williams & Mills, 1970) . There was, however, an indication of reduced total pancreatic Zn in diabetic mice fed on the low-Zn diet. The lower pancreatic Zn concentration observed in the diabetic mice fed at both levels of Zn compared with heterozygotes, is probably related to their hyperinsulinaemia, the early onset of /?-cell degradation and other pathological changes in this tissue associated with the progression of the condition (Coleman & Hummel, 1967) , and is consistent with human studies showing that the pancreatic Zn concentration of diabetics is depressed compared with normals (Scott & Fisher, 1938) . The marked reduction in femur Zn concentrations in genetically diabetic mice, compared with heterozygote littermates, reported by Levine et al.
(1 983), was not confirmed by the present study. There were indications that bone Zn concentration was slightly lower in the diabetic animals, but the difference was not always significant.
Despite the apparently negligible effects of consuming the low-Zn diet on growth and Zn status of mice used in the present study, significant differences in glucose metabolism were observed. In the first experiment, where the time of feeding was strictly controlled and the amount of food eaten by each animal before an overnight fast was known to be similar, the mean fasting blood glucose concentration in the low-Zn diabetic mice was found to be 23 YO higher than that for the control diabetic group. This suggests that the lower Zn intake had exacerbated the reduced ability of the diabetic mice to utilize glucose. In the second experiment, where blood glucose was measured after normal ad lib. feeding, low-Zn diabetic mice were again found to have elevated blood glucose concentrations and there was some indication of abnormal glucose utilization in the low-Zn heterozygote animals. Although there was no evidence from the first experiment of a difference in feeding pattern between dietary groups, investigations to verify the increased blood glucose concentrations observed in the second experiment should be repeated under conditions of strict dietary control. Results from the present study, and those of a previous study showing increased blood glucose concentations after oral dosing in rats fed on a marginal-Zn diet in late pregnancy (Southon et al. 1988 a) , suggest a relation between carbohydrate utilization and dietary Zn supply, particularly in conditions associated with hyperinsulinaemia and tissue insulin resistance. Since circulating insulin levels in both studies were unaffected by the reduced dietary Zn intake, the possibility of increased insulin resistance or reduced physiological potency of the hormone should be. considered.
Aside from the well-known large accumulation of subcutaneous fat in the genetically diabetic mice, the most striking anatomical deviation is the size of the liver, which is in part due to metabolic defects resulting in increased fat and glycogen deposition (Coleman & Hummel, 1967) . In the present study, the livers of 8-9-week-old diabetic mice were two to three times heavier than their heterozygote littermates and it was noted that livers from low-Zn diabetic mice were significantly heavier than those from their control counterparts. In addition, the fasting glycogen content of the low-Zn diabetic mice was approximately 48 % higher than in the control diabetic animals, although food intake on the day before death was similar for these two groups. This again indicates that the carbohydrate metabolism of these animals is sensitive to reduced Zn intake. It is interesting to note that Reeves & O'Dell(1983) also found evidence of increased glycogen synthesis in Zn-deficient rats. In the present study it was difficult to ascertain whether there was any effect of diet on glycogen deposition in the heterozygote mice since only small amounts of glycogen were detectable in the fasted state, and no analyses were performed in the 'fed' animals because of the difficulty of determining food intake in the second study.
Results from the 'j5Zn study clearly demonstrated the ability of both mouse genotypes to reduce 65Zn loss when dietary Zn intake was restricted. This may have been achieved by decreased endogenous Zn secretion into the gastrointestinal tract (Jackson et al. 1984) or increased efficiency of absorption of Zn from the diet (Wada et al. 1985) , or both. The diabetic condition also had a significant effect on 'j5Zn loss, in that the loss was significantly greater in low-Zn diabetic mice than in the non-diabetic heterozygote. It appears, therefore, that the diabetic mice were less able to adapt to conditions of reduced dietary Zn intake. In contrast, 'j5Zn loss from both genotypes fed on the control diet was similar. It was also noted that, whereas the low-Zn diabetic mice had a significantly lower femur Zn concentration than low-Zn heterozygotes in the present experiment, there was no significant difference between control groups ( Table 3) . Although the rate of whole-body 'j5Zn turnover is known to be directly related to dietary Zn intake (Huber & Gershoff, 1970) , it is unlikely that the increased loss of 65Zn from low-Zn diabetic mice was related to their higher food intake compared with heterozygotes; first, because the Zn content of the low-Zn diet was such that the observed increase in food consumption would not have influenced the rate of body Zn turnover and second, because no difference in 65Zn loss was found between genotypes fed on the control diet. The route of loss of 'j5Zn was not determined in the present experiment, but there are reports in the literature describing a higher Zn concentration in the urine of genetically diabetic mice (Levine et al. 1983) . However, little is known about the efficiency of Zn absorption in these animals, and any difference in absorption between genotypes could have influenced rates of 65Zn loss. Clearly more detailed studies are required to gain a better understanding of the complex metabolic changes observed.
In conclusion, findings presented in the present paper demonstrate that reduced Zn intake had an adverse effect on glucose utilization in the genetically diabetic mouse, although changes in Zn status appeared to be minimal. It appears, therefore, that abnormalities in carbohydrate metabolism may occur before tissue Zn depletion becomes apparent.
